Stable Formulations of SHR0302
Copyright © Targeted News Service 2024
2024-12-10
ALEXANDRIA, Virginia, Dec. 10 -- ARCUTIS BIOTHERAPEUTICS, INC., Westlake Village, California has been assigned a patent (No. US 12161643 B2, initially filed Dec. 14, 2022) developed by Herbert R. Brinkman, Fort Collins, Colorado, and Jason Michael Carbol, Petaluma, California, for "Stable formulations of SHR0302." . . .